Laboratory-Grade Somatropin for Advanced Research
Hygetropin 100 IU is a pharmaceutical-grade recombinant human growth hormone preparation extensively utilised in laboratory research investigating growth factor signalling pathways, cellular metabolism, and tissue development mechanisms. This somatropin formulation demonstrates identical amino acid sequence to endogenous human growth hormone, produced through recombinant DNA technology in bacterial expression systems. Research applications encompass studies examining IGF-1 pathway activation, protein synthesis regulation, and metabolic homeostasis in various experimental models.
Research Applications and Mechanisms
Investigators studying growth hormone biology utilise this compound to examine its effects on cellular proliferation, differentiation, and metabolic processes. The somatropin molecule binds to growth hormone receptors, activating JAK-STAT signalling cascades that influence gene expression patterns associated with growth and metabolism. Research demonstrates its role in stimulating hepatic IGF-1 production, modulating glucose homeostasis, and affecting lipid metabolism in experimental systems. Laboratories at Stroid UK Shop frequently investigate these mechanisms alongside studies involving selective androgen receptor modulators and research peptides to understand comprehensive growth factor interactions. The compound’s effects on cellular energy expenditure and anabolic processes make it valuable for metabolic research conducted within our growth hormone research category.
Technical Specifications
| Compound Classification | Recombinant Human Growth Hormone |
|---|---|
| Molecular Weight | 22,124 Da |
| Amino Acid Sequence | 191 amino acids (identical to hGH) |
| Formulation | 100 IU pharmaceutical preparation |
| Storage Requirements | 2-8°C refrigerated storage |
| Research Applications | Growth factor studies, metabolic research |
Research Compliance Statement
Hygetropin 100 IU is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and applicable regulations governing growth hormone research compounds in their jurisdiction.
